Intended for healthcare professionals

Short Reports

Seven alternatives to evidence based medicine

BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7225.1618 (Published 18 December 1999) Cite this as: BMJ 1999;319:1618

Re: Seven alternatives to evidence based medicine

A handful of academics have called the shots regarding the diagnosis and treatment of Lyme disease. We have a worldwide patient population living with a chronic relapsing infection with limited treatment options as mainstream medicine is following the so called “evidence based medicine.”

 

When “evidence based medicine” has been spun to fit bias agendas and the patient voice has been intentionally ignored who investigates the dishonest science?

 

From the petition site: Calling for a Congressional investigation of the CDC, IDSA and ALDF

 

It’s all about the VACCINE

It has become blatantly obvious that the CDC will go to great lengths to insure that Lyme disease remains within its narrow definition in order to fit the vaccine model. Chronic Lyme does not fit any vaccine model. 

The CDC has long known about the virulence and persistence of this spirochete focusing on a vaccine as the cure-all to this world wide epidemic. The late stage/chronic Lyme community has become collateral damage for a vaccine market in the course of a government sponsored initiative as Baxter’s phase III clinical trials are underway.

The CDC has aligned itself with institutions/researchers with a bias against persistent infection and has misused its authority by inappropriately allotting government funds to Mass General Hospital (Dr Alan Steere) and New York Medical College (Dr Gary Wormser) as identified in the following communications. Read more….

The Principle Investigators of the two previous Lyme vaccines: Allen C. Steere for SmithKlineBeecham's LymeRix and Gary Wormser for Connaught's vaccine (which never made it to market) have conceptualized a disease that would enable vaccine development. The one-size-fits-all Lyme treatment guideline (lead author: Gary Wormser) matches the conceptualized disease.

A preventive vaccine for Lyme disease would not satisfy the FDA if a chronic persistent infection and seronegative disease exist.  

Seronegativity in Lyme borreliosis: 103 Peer-Reviewed Studies

It remains questionable that a Lyme disease vaccine is practical for an infection that produces a lack of immunological memory (unlike Measles, Mumps etc.) so the Wormser study fabricating a six year strain-specific immunity makes perfect sense for the marketing/acceptance of such vaccine as identified in a letter to Editor in Chief, Ferric C. Fang, M.D. Infection and Immunity.  Read more…


Respectfully submitted,

 

Carl Tuttle

33 David Dr

 

Hudson,NH03051

Competing interests: No competing interests

01 April 2014
Carl Tuttle
Lyme Disease Advocate
World Lyme Patient Population
33 David Dr Hudson, NH 03051